Ten years of R&D and full automation in molecular diagnosis

Future Microbiol. 2016;11(3):403-25. doi: 10.2217/fmb.15.152.

Abstract

A 10-year experience of our automated molecular diagnostic platform that carries out 91 different real-time PCR is described. Progresses and future perspectives in molecular diagnostic microbiology are reviewed: why automation is important; how our platform was implemented; how homemade PCRs were developed; the advantages/disadvantages of homemade PCRs, including the critical aspects of troubleshooting and the need to further reduce the turnaround time for specific samples, at least for defined clinical settings such as emergencies. The future of molecular diagnosis depends on automation, and in a novel perspective, it is time now to fully acknowledge the true contribution of molecular diagnostic and to reconsider the indication for PCR, by also using these tests as first-line assays.

Keywords: assay development; automation; flexibility; high-throughput tests; intracellular bacteria; molecular diagnosis; quality assessment; real-time PCR.

Publication types

  • Review

MeSH terms

  • Automation*
  • Humans
  • Infections / diagnosis*
  • Molecular Diagnostic Techniques*
  • Real-Time Polymerase Chain Reaction* / instrumentation
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Time Factors